Nyxoah Correlations
NYXH Stock | USD 10.00 0.36 3.47% |
The current 90-days correlation between Nyxoah and Milestone Scientific is 0.14 (i.e., Average diversification). The correlation of Nyxoah is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Nyxoah Correlation With Market
Average diversification
The correlation between Nyxoah and DJI is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Nyxoah and DJI in the same portfolio, assuming nothing else is changed.
Nyxoah |
Moving together with Nyxoah Stock
0.81 | ANGO | AngioDynamics | PairCorr |
0.79 | CUE | Cue Biopharma | PairCorr |
0.81 | OPT | Opthea Earnings Call Today | PairCorr |
0.83 | GANX | Gain Therapeutics | PairCorr |
0.75 | TMO | Thermo Fisher Scientific | PairCorr |
0.64 | WAT | Waters | PairCorr |
0.81 | LTRN | Lantern Pharma | PairCorr |
0.74 | PHGE | Biomx Inc | PairCorr |
Moving against Nyxoah Stock
0.67 | EXAS | EXACT Sciences | PairCorr |
0.54 | TFX | Teleflex Incorporated | PairCorr |
0.44 | EDIT | Editas Medicine Earnings Call Today | PairCorr |
0.41 | COO | Cooper Companies, Earnings Call Today | PairCorr |
0.38 | DHR | Danaher | PairCorr |
0.33 | UNH | UnitedHealth Group | PairCorr |
0.89 | INZY | Inozyme Pharma | PairCorr |
0.86 | ADTX | Aditxt Inc | PairCorr |
0.81 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.6 | KURA | Kura Oncology | PairCorr |
0.55 | ILMN | Illumina | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Nyxoah Stock performing well and Nyxoah Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Nyxoah's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
MLSS | 4.52 | 0.79 | 0.18 | 0.56 | 4.07 | 9.88 | 35.99 | |||
PDEX | 4.08 | (0.19) | 0.00 | (0.11) | 0.00 | 7.75 | 34.56 | |||
INFU | 2.10 | (0.19) | 0.00 | (0.17) | 0.00 | 4.40 | 14.39 | |||
KRMD | 2.98 | 0.28 | 0.08 | 0.23 | 3.10 | 8.65 | 23.89 | |||
ZJYL | 6.65 | (0.51) | 0.00 | (0.25) | 0.00 | 14.29 | 38.64 | |||
NXGL | 3.91 | 0.15 | 0.03 | 0.10 | 4.49 | 9.22 | 27.48 | |||
DXR | 1.92 | (0.27) | 0.00 | (0.41) | 0.00 | 3.46 | 12.40 | |||
LMAT | 1.37 | 0.01 | 0.01 | 0.02 | 2.19 | 2.32 | 11.04 | |||
UTMD | 0.70 | (0.15) | 0.00 | (0.32) | 0.00 | 1.10 | 4.93 |
Nyxoah Corporate Management
Jeremy Feffer | VP Communication | Profile | |
Dorit Nahari | VP Operations | Profile | |
An Moonen | General Counsel | Profile | |
John Landry | Chief Officer | Profile | |
Francis Kim | Chief Officer | Profile | |
Mikaela Kirkwood | Corporate Manager | Profile |